DiaMedica Therapeutics Statistics
Total Valuation
DMAC has a market cap or net worth of $181.83 million. The enterprise value is $143.11 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
DMAC has 42.88 million shares outstanding. The number of shares has increased by 17.44% in one year.
Current Share Class | 42.88M |
Shares Outstanding | 42.88M |
Shares Change (YoY) | +17.44% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 38.58% |
Owned by Institutions (%) | 17.76% |
Float | 24.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.30 |
P/TBV Ratio | 5.30 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.02, with a Debt / Equity ratio of 0.01.
Current Ratio | 8.02 |
Quick Ratio | 7.84 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.25% and return on invested capital (ROIC) is -44.88%.
Return on Equity (ROE) | -67.25% |
Return on Assets (ROA) | -41.27% |
Return on Invested Capital (ROIC) | -44.88% |
Return on Capital Employed (ROCE) | -85.13% |
Revenue Per Employee | n/a |
Profits Per Employee | -$964,286 |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, DMAC has paid $29,000 in taxes.
Income Tax | 29,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.73% in the last 52 weeks. The beta is 1.29, so DMAC's price volatility has been higher than the market average.
Beta (5Y) | 1.29 |
52-Week Price Change | +43.73% |
50-Day Moving Average | 3.94 |
200-Day Moving Average | 4.73 |
Relative Strength Index (RSI) | 54.14 |
Average Volume (20 Days) | 112,971 |
Short Selling Information
The latest short interest is 856,926, so 2.00% of the outstanding shares have been sold short.
Short Interest | 856,926 |
Short Previous Month | 619,688 |
Short % of Shares Out | 2.00% |
Short % of Float | 3.55% |
Short Ratio (days to cover) | 8.95 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.08M |
Pretax Income | -19.85M |
Net Income | -27.00M |
EBITDA | -29.04M |
EBIT | -29.08M |
Earnings Per Share (EPS) | -$0.65 |
Full Income Statement Balance Sheet
The company has $36.32 million in cash and $316,000 in debt, giving a net cash position of $37.00 million or $0.86 per share.
Cash & Cash Equivalents | 36.32M |
Total Debt | 316,000 |
Net Cash | 37.00M |
Net Cash Per Share | $0.86 |
Equity (Book Value) | 33.95M |
Book Value Per Share | 0.79 |
Working Capital | 32.76M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$22.57 million and capital expenditures -$28,000, giving a free cash flow of -$22.60 million.
Operating Cash Flow | -22.57M |
Capital Expenditures | -28,000 |
Free Cash Flow | -22.60M |
FCF Per Share | -$0.53 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DMAC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.44% |
Shareholder Yield | -17.44% |
Earnings Yield | -14.99% |
FCF Yield | -12.55% |
Analyst Forecast
The average price target for DMAC is $8.00, which is 88.68% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 88.68% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 15, 2018. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Nov 15, 2018 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |